Loading...

World-Class Retina Care. Community-Based Caring.

Dr. Abbey and Dr. Williams Co-authored Article Published in Ophthalmology on the Influence of Face Mask Use on Endophthalmitis Risk After Eye Injections

Posted On June 7, 2021 / By / Posted in Blog

Dr. Abbey and Dr. Williams Co-authored Article Published in Ophthalmology on the Influence of Face Mask Use on Endophthalmitis Risk After Eye Injections

Texas Retina Associates’ Ashkan Abbey, MD, and Patrick D. Williams, MD, co-authored a recently published article titled “The Influence of Universal Face Mask Use on Endophthalmitis Risk After Intravitreal Anti-VEGF Injections During

read more
Posted On March 22, 2021 / By / Posted in Blog

Dr. Choi’s Research on Filtering-associated Endophthalmitis in Ophthalmology Retina Journal

Texas Retina Associates’ Rene Y. Choi, MD, PhD, published an article titled “Filtering-Associated Endophthalmitis after Trabeculectomy or Tube-Shunt Implant” in the March 2021 issue of Ophthalmology Retina.  The article highlights the results of

read more
Posted On October 26, 2020 / By / Posted in Blog

Dr. Choi’s Research on Utilizing Artificial Intelligence to Aid in the Diagnosis of Plus Disease in Retinopathy of Prematurity Patients Published in Ophthalmology Retina

Texas Retina Associates’ Rene Y. Choi, MD, published an article titled “Variability in Plus Disease Identified Using a Deep Learning-Based Retinopathy of Prematurity Severity Scale” in the latest issue of Ophthalmology Retina,

read more
Posted On July 22, 2020 / By / Posted in Blog

Texas Retina Associates Participating in Pagoda Clinical Trial for Diabetic Macular Edema

Sponsored by Genentech, the Pagoda clinical trial is studying an investigational drug delivery system for diabetic macular edema (DME) treatment to see if it could result in fewer eye injections and eye

read more